Neoadjuvant chemotherapy is less costly than primary debulking surgery for treatment of advanced stage ovarian cancer in patients≥65years old
Year: 2013
Type: article
Source: Gynecologic Oncology
Authors: M. Rowland, C. Farris, J. Lesnock, T. Krivak
Institutions: Magee-Womens Hospital, RAND Corporation
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2013995392
